INTRODUCTION: There have been reports of thalidomide-affected people suffering a deterioration in their disability over time [1, 2]. This study assessed changes in disabilities among thalidomide-affected people in the Irish population. METHODS: A questionnaire, assessing musculo-skeletal health, quality-of-life, general health and illness intrusiveness was sent to 26 people affected by thalidomide in the Republic of Ireland. RESULTS: Seventeen (65%) responded. Six (35%) respondents were not working as a result of their disability. Eleven (65%) reported a worsening of their disability over time, with nine of them reporting the deterioration as moderate to severe. The impact of this decline was measured by respondents in terms of ability to perform daily tasks, emotional health and finances (due to extra costs related to clothing, transport, housing alterations and heating). CONCLUSION: There is a need to continually review the physical, psychological and social needs of thalidomide survivors in order to ensure optimum care is made available.
INTRODUCTION: There have been reports of thalidomide-affected people suffering a deterioration in their disability over time [1, 2]. This study assessed changes in disabilities among thalidomide-affected people in the Irish population. METHODS: A questionnaire, assessing musculo-skeletal health, quality-of-life, general health and illness intrusiveness was sent to 26 people affected by thalidomide in the Republic of Ireland. RESULTS: Seventeen (65%) responded. Six (35%) respondents were not working as a result of their disability. Eleven (65%) reported a worsening of their disability over time, with nine of them reporting the deterioration as moderate to severe. The impact of this decline was measured by respondents in terms of ability to perform daily tasks, emotional health and finances (due to extra costs related to clothing, transport, housing alterations and heating). CONCLUSION: There is a need to continually review the physical, psychological and social needs of thalidomide survivors in order to ensure optimum care is made available.
Authors: G M Devins; H Mandin; R B Hons; E D Burgess; J Klassen; K Taub; S Schorr; P K Letourneau; S Buckle Journal: Health Psychol Date: 1990 Impact factor: 4.267
Authors: Gerald M Devins; Susan J Armstrong; Henry Mandin; Leonard C Paul; Ronald B Hons; Ellen D Burgess; Kenneth Taub; Samuel Schorr; P K Letourneau; Sherry Buckle Journal: Pain Date: 1990-09 Impact factor: 6.961
Authors: G Devins; M Flanigan; J Fleming; R Morehouse; A Moscovitch; J Plamondon; L Reinish; C Shapiro Journal: Eur Psychiatry Date: 1995 Impact factor: 5.361
Authors: Alexander Niecke; Klaus Peters; Christina Samel; Kristin Forster; Markus Lüngen; Holger Pfaff; Christian Albus Journal: Dtsch Arztebl Int Date: 2017-03-10 Impact factor: 5.594